The cannabinoid agonist WIN55212 reduces brain damage in an in vivo model of hypoxic-ischemic encephalopathy in newborn rats.

Fernández-López, David

The cannabinoid agonist WIN55212 reduces brain damage in an in vivo model of hypoxic-ischemic encephalopathy in newborn rats. [electronic resource] - Pediatric research Sep 2007 - 255-60 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0031-3998

10.1203/PDR.0b013e318123fbb8 doi


Analgesics--pharmacology
Animals
Animals, Newborn
Benzoxazines--pharmacology
Brain--anatomy & histology
Cannabinoids--agonists
Hypoxia-Ischemia, Brain--pathology
Magnetic Resonance Imaging
Morpholines--pharmacology
Naphthalenes--pharmacology
Neuroprotective Agents--pharmacology
Random Allocation
Rats
Rats, Wistar